Stay updated with breaking news from Complete Genomic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests
/PRNewswire/ -- Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete...
The companies will collaborate to develop biomarkers tests for minimal residual disease (MRDs) in research and clinical setting using the DNBSeq sequencer.
Activist investor Carl C. Icahn says he will nominate three allies to Illumina's board who will press the company to sell off cancer blood test developer Grail.
Advances in Genome Biology and Technology delivers cutting-edge genomics news by day, holds beachside festivities (enlivened by Flo Rida’s “Low”) at night.